Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 3rd Quarter - Termination (No Activity)

DISCOVERY LABORATORIES

via DALRYMPLE & ASSOCIATES, LLC

3rd Quarter (July 1 - Sep 30) · 2013Posted Oct 18, 2013Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: DISCOVERY LABORATORIES
Description: Biodefense & Civilian Drug Development
Location: Pennsylvania · United States of America

Registrant

Firm: DALRYMPLE & ASSOCIATES, LLC
Description: Business Consulting
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

DISCOVERY LABORATORIES — Lobbying — Receipts Report